Epidemiology
-
Efficacy of two doses of COVID-19 vaccine against severe COVID-19 in those with risk conditions and residual risk to the clinically extremely vulnerable: the REACT-SCOT case-control study
This article has 8 authors:Reviewed by ScreenIT
-
What pushed Israel out of herd immunity? Modeling COVID-19 spread of Delta and Waning immunity
This article has 2 authors:Reviewed by ScreenIT
-
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study
This article has 6 authors:Reviewed by ScreenIT
-
Social-economic drivers overwhelm climate in underlying the COVID-19 early growth rate
This article has 1 author:Reviewed by ScreenIT
-
Scale-free dynamics of COVID-19 in a Brazilian city
This article has 12 authors:Reviewed by ScreenIT
-
Effectiveness of Mass Vaccination in Brazil against Severe COVID-19 Cases
This article has 14 authors:Reviewed by ScreenIT
-
Assessing the asymptomatic proportion of SARS-CoV-2 infection with age in China before mass vaccination
This article has 15 authors:Reviewed by ScreenIT
-
CHARACTERIZING AND MANAGING AN EPIDEMIC: A FIRST PRINCIPLES MODEL AND A CLOSED FORM SOLUTION TO THE KERMACK AND MCKENDRICK EQUATIONS
This article has 2 authors:Reviewed by ScreenIT
-
A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia
This article has 9 authors:Reviewed by ScreenIT
-
SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency
This article has 15 authors:Reviewed by ScreenIT